Advanced/ Metastatic Renal Cell Cancer
1 clinical trials · Condition
◉ Watch Advanced/ Metastatic Renal Cell Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer (NCT00715182) | Novartis Pharmaceuticals | 2008-07-01 |
Track Advanced/ Metastatic Renal Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.